Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab for Diabetic Macular Edema
NCT00703235Phase 3Unknown
- Sponsor
- Isfahan Ophthalmology Research Center
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of bevacizumab in diabetic macular edema (DME), sponsored by Isfahan Ophthalmology Research Center. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00703235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00703235.